Upstream stimulating factor 1 (USF1) -202 G/A polymorphism and serum levels of USF1 and USF2 are associated with gastric cancer risk: a case control study
USF1-202 G/A polymorphism constitutes a gastric cancer genetic risk factor. Together with USF1/USF2 serum level, they can be proposed as promising biomarkers for gastric cancer detection/prevention.
Authors
- Ilhame Elyounsi
- Imane Essaidi (ORCID: https://orcid.org/0000-0003-4610-5978)
- Mohamed Reda Jouimyi (ORCID: https://orcid.org/0000-0002-5078-6684)
- Fatima Maachi (ORCID: https://orcid.org/0000-0002-9635-1045)
- Eliette Touati (ORCID: https://orcid.org/0000-0002-3450-1773)
- Hasna Boura (ORCID: https://orcid.org/0000-0003-3880-1615)
- Ghizlane Bounder (ORCID: https://orcid.org/0000-0003-3725-0516)
- Valérie Michel (ORCID: https://orcid.org/0000-0003-0681-5588)
- W. Badre
Institutions
- Université de Tours (FR)
- Centre National de la Recherche Scientifique (FR)
- Institut Pasteur (FR)
- Université Paris Cité (FR)
- Centre Hospitalier Universitaire Ibn Rochd (MA)
- Institut Pasteur du Maroc (MA)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1007/s00432-025-06158-1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00